VZV ORF29 mutant-based vaccine (National Institute of Allergy and Infectious Diseases)

N/A

Report date: 2025/03/20 09:47:16

Base Information

Drug NameVZV ORF29 mutant-based vaccine (National Institute of Allergy and Infectious Diseases)
Drug Alias Namevaricella-Zoster virus open reading frame 29 mutant-based vaccine (National Institute of Allergy and Infectious Diseases)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsVaricella Zoster Virus Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
China Registration ClassN/A

Develop Information

Active CompaniesUs Department Of Health And Human ServicesNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsVaricella Zoster Virus Infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A